Article Information
History
- September 16, 2017.
Article Versions
- Version 1 (September 15, 2017 - 14:25).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Francesca Th’ng1,
- Bastiaan Vliegenthart2,
- Jonathan D Lea3,
- Daniel J. Antoine3,
- James W Dear2 and
- Damian J. Mole1,4
- 1Clinical Surgery, School of Clinical Sciences and Community Health, The University of Edinburgh, U.K.
- 2University of Edinburgh/BHF Centre for Cardiovascular Science.
- 3MRC Centre for Drug Safety Science, University of Liverpool.
- 4MRC Centre for Inflammation Research, Queen’s Medical Research Institute, The University of Edinburgh, U.K.
- 5Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, U.K.
- *CORRESPONDING AUTHOR AND ADDRESS: Miss Francesca Th’ng, Department of Surgery, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh, EH16 4SA. Tel: +44 (0) 131 242 3616 Fax: +44 (0) 131 242 3617 Email: Francesca.thng{at}nhs.net
Posted September 16, 2017.
Biomarker evaluation of plasma microRNA-122, high-mobility group box-1 and keratin-18 in acute gallstone disease
